$27.21
1.59[6.21%]
At close: May 1
$27.21
0[0.00%]
After Hours: 7:59PM EDT
Latest News for Pfizer Stock (NYSE:PFE)
Pfizer Stock (NYSE: PFE)
Categories: All
Thursday, May 02, 2024
Wednesday, May 01, 2024
- Carvana, Enovix, Pfizer, Nio, Tesla: Why These 5 Stocks Are On Investors' Radars TodayBenzinga Neuro - 3 hours ago
- Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top EstimatesAvi Kapoor - 12 hours ago
- US Stocks Mixed Ahead Of Fed Meeting, Chipmakers Tumble After AMD Earnings, Bitcoin Sinks: What's Driving Markets Wednesday?Piero Cingari - 13 hours ago
- Pfizer Exec Says Co Is Progressing On Retail Contracting For RSV Vaccine; RSV Vaccine Performance Was In Line With Expectations In QTR; Patent Term Extension, If Granted, Could Extend U.S. Exclusivity For Heart Disease Drug Vyndamax To Dec 2028Benzinga Newsdesk - 15 hours ago
- Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With ExpectationsVandana Singh - 16 hours ago
- GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual OutlookVandana Singh - 17 hours ago
- Pfizer Sees FY24 Revenues $58.5B-$61.5B Vs $62.92B EstimateBenzinga Newsdesk - 20 hours ago
- Pfizer Sees FY24 Adj. EPS $2.15-$2.35 Vs $2.76 EstimateBenzinga Newsdesk - 20 hours ago
- Pfizer shares are trading higher after the company reported better-than-expected Q1 financial results.Benzinga Newsdesk - 20 hours ago
- Pfizer Q1 2024 Adj EPS $0.82 Beats $0.54 Estimate, Sales $14.90B Beat $14.20B EstimateBenzinga Newsdesk - 20 hours ago
- FT Earlier Reported Pfizer To Sell Covid And Migraine Drugs Directly To ConsumersBenzinga Newsdesk - 20 hours ago
- Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer RallyShanthi Rexaline - 20 hours ago
- Investor Sentiment Falls, Dow Snaps Five-Month Win StreakAvi Kapoor - 23 hours ago
- Amazon, Pfizer And 3 Stocks To Watch Heading Into WednesdayAvi Kapoor - 23 hours ago
Tuesday, April 30, 2024
Monday, April 29, 2024
- FDA OKs Seagen's Tivdak (tisotumab vedotin-tftv) For Cervical CancerBenzinga Newsdesk - 2 days ago
- What Makes Amazon Attractive Ahead of Q1 Earnings?Zacks - 2 days ago
- mRNA Is Promising A Breakthrough In Fighting CancerUpwallstreet - 2 days ago
- FDA Approves Labcorp's nAbCyte Anti-AAVRh74var HB-FE, Companion Diagnostic To Determine Patient Eligibility For Treatment With Beqvez (Fidanacogene Elaparvovec-dzkt), Pfizer's Recently FDA-Approved Hemophilia B Gene TherapyBenzinga Newsdesk - 2 days ago
- Pfizer to Present Cancer Therapies at ASCO Annual Meeting, Including Advances in ADCs and Bispecific AntibodiesBenzinga Newsdesk - 2 days ago
- Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This WeekShanthi Rexaline - 3 days ago
Friday, April 26, 2024
- COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent BattleVandana Singh - 5 days ago
- FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder HemophiliaVandana Singh - 5 days ago
- Pfizer's Options: A Look at What the Big Money is ThinkingBenzinga Insights - 5 days ago
- Pfizer Says U.S. FDA Approved Company's BEQVEZ (fidanacogene elaparvovec-dzkt), A One-Time Gene Therapy For Adults With Hemophilia B; Company Now Plans Launching An Innovative Warranty Program Based On Durability Of Patient Response To TreatmentBenzinga Newsdesk - 5 days ago
Thursday, April 25, 2024
- Bristol-Myers Q1 Loss Narrower Than Expected, Sales BeatZacks - 6 days ago
- Pfizer and BioNTech shares are trading lower amid reports GSK is suing the companies alleging patent infringement concerning mRNA technology used in their COVID-19 vaccines.Benzinga Newsdesk - 6 days ago
- What's Going On With Pfizer Stock On Thursday?Vandana Singh - 6 days ago
- Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend YieldsAvi Kapoor - 6 days ago
Wednesday, April 24, 2024
Tuesday, April 23, 2024
Monday, April 22, 2024
Thursday, April 18, 2024
Tuesday, April 16, 2024
Monday, April 15, 2024
Thursday, April 11, 2024
Wednesday, April 10, 2024
- Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst SaysVandana Singh - Apr 10, 2024, 2:42PM
- The Pharmaceutical Industry Finds Itself At A Historical CrossroadsUpwallstreet - Apr 10, 2024, 10:47AM
- PM Fumio Kishida Urges US Tech Giants To Invest In Japan: 'I'm Strongly Promoting Policies Toward The Next Economic Stage'Benzinga Neuro - Apr 10, 2024, 5:24AM
Tuesday, April 09, 2024
- Pfizer Seeks Expanded Use Of Abrysvo As Vaccine Shows Potential In 18+ PatientsVandana Singh - Apr 9, 2024, 12:20PM
- Decoding Pfizer's Options Activity: What's the Big Picture?Benzinga Insights - Apr 9, 2024, 10:01AM
- Pfizer Announces Top-Line Results From Phase 3 Study Of ABRYSVO In Adults Aged 18 To 59 At Increased Risk For RSV DiseaseBenzinga Newsdesk - Apr 9, 2024, 6:46AM